Skip to main content
← Companies
SLNO

SOLENO THERAPEUTICS INC

Data as of Sep 17, 2026
SLNO
CIK 1484565Pharmaceutical Preparations

Lobbying

$440,000 in reported federal lobbying spend across 11 quarterly filings, most recently Jul 28, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Spend by issue

  • Health Issues$280K7 filings
  • Pharmacy +6$150K2 filings

Latest filings, Apr 2026 onward

FiledRegistrant and subjectAmount
Jul 28, 2026
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS INC.
Health Issues HR 5509/S.2903 Safe Step Act HR 6423/S. 864 HELP Copays Act
$10,000
Jul 20, 2026
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS INC.
Pharmacy · Trade (domestic/foreign) · Financial Institutions/Investments/Securities · Health Issues · Medicare/Medicaid · Insurance · Economics/Economic Development H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, E
$70,000
Jul 19, 2026
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS INC.
Unspecified
$10,000
May 8, 2026
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS INC.
Pharmacy · Trade (domestic/foreign) · Financial Institutions/Investments/Securities · Health Issues · Medicare/Medicaid · Insurance · Economics/Economic Development H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, E
$80,000
May 4, 2026
SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS INC.
Financial Institutions/Investments/Securities · Health Issues · Medicare/Medicaid · Insurance · Pharmacy · Trade (domestic/foreign) · Economics/Economic Development H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, EPIC Act; Most Favored Nation, orphan drug exemption H.R.7118, Genomic Answers for Childrens Health Act; H.R.1414, Camerons Law; H.R.1492/S.832, E
$0
Apr 20, 2026
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS INC.
Health Issues H.R.7118, Genomic Answers for Childrens Health Act H.R.1414, Camerons Law H.R.1492/S.832, EPIC Act S.3019, No Big Blockbuster Bailouts Act
$20,000

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to SOLENO THERAPEUTICS INC through its SEC registration (CIK 1484565) and tickers SLNO.

As of: lobbying filings through Jul 28, 2026; contract actions through Aug 5, 2025. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.